Coverage
-
March 03, 2023
Amgen and Teva told a Delaware federal court it has the authority to grant their request for an immediate appeal of a prior judge's refusal to toss a case accusing them of cutting an illegal deal to remove a generic calcium control drug from the market.
1 other articles on this case.
View all »